Pictet Asset Management Holding Sa Vertex Pharmaceuticals Inc Transaction History
Pictet Asset Management Holding Sa
- $90.1 Billion
- Q1 2024
A detailed history of Pictet Asset Management Holding Sa transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 998,294 shares of VRTX stock, worth $468 Million. This represents 0.46% of its overall portfolio holdings.
Number of Shares
998,294
Previous 1,081,046
7.65%
Holding current value
$468 Million
Previous $440 Million
5.13%
% of portfolio
0.46%
Previous 0.49%
Shares
3 transactions
Others Institutions Holding VRTX
# of Institutions
1,623Shares Held
222MCall Options Held
1.35MPut Options Held
1.49M-
Capital World Investors Los Angeles, CA25.6MShares$12 Billion1.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA22.7MShares$10.6 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY22MShares$10.3 Billion0.22% of portfolio
-
State Street Corp Boston, MA12MShares$5.63 Billion0.23% of portfolio
-
Alliancebernstein L.P. New York, NY7.1MShares$3.33 Billion1.08% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $120B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...